217 studies found for:    "Diabetic Nephropathies"
Show Display Options
RSS Create an RSS feed from your search for:
"Diabetic Nephropathies"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting A Study in Patients With Diabetic Kidney Disease
Conditions: Diabetic Kidney Disease;   Diabetic Nephropathy;   Diabetic Glomerulosclerosis
Interventions: Drug: LY2382770;   Drug: Placebo
2 Recruiting Pyridorin in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetic Kidney Disease
Interventions: Drug: Pyridorin;   Drug: Placebo
3 Recruiting N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
Conditions: Diabetic Nephropathies;   Proteinuria;   Oxidative Stress
Interventions: Dietary Supplement: N-acetylcysteine;   Dietary Supplement: silibin;   Dietary Supplement: high-dose silibin;   Dietary Supplement: N-acetylcysteine placebo;   Dietary Supplement: silibin placebo
4 Recruiting Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
Conditions: Diabetes Mellitus, Type 2;   Diabetic Nephropathies
Interventions: Drug: Canagliflozin;   Drug: Placebo
5 Enrolling by invitation Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease
Conditions: Diabetic Nephropathies;   Hypertension
Interventions: Dietary Supplement: Standardized salt diet;   Drug: Amiloride
6 Active, not recruiting Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)
Condition: Diabetic Nephropathies
Interventions: Drug: BAY94-8862;   Drug: Placebo;   Drug: BAY 94-8862
7 Completed INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy
Condition: Diabetic Nephropathies
Interventions: Drug: Telmisartan capsule 40 mg;   Drug: Placebo;   Drug: Telmisartan capsule 80 mg
8 Completed Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease
Conditions: Diabetes Mellitus, Type I;   Diabetic Nephropathy
Intervention: Drug: Lisinopril
9 Active, not recruiting Minocycline and Proteinuria in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Minocycline 100 mg po bid for 6 months;   Drug: placebo
10 Recruiting Glutathione in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Proteinuria;   Oxidative Stress
Interventions: Drug: N-acetylcysteine placebo + silibin placebo;   Drug: N-acetylcysteine active + silibin placebo;   Drug: N-acetylcysteine placebo + silibin active;   Drug: N-acetylcysteine active + silibin active;   Drug: N-acetylcysteine active + high-dose silibin active
11 Completed Nitric Oxide (NO) Activity and Diabetic Nephropathy
Condition: Diabetic Nephropathies
Intervention: Drug: Folic Acid
12 Completed Spironolactone in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Spironolactone
13 Completed Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy
Conditions: Diabetic Nephropathies;   Diabetes Mellitus, Type II
Intervention: Drug: EDTA chelating agents
14 Completed Soy Protein in Early Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetes Mellitus
Intervention: Drug: soy protein
15 Completed Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: spironolactone
16 Unknown  Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease
Intervention: Drug: Mycophenolate Mofetil (MMF) ,phosphodiesterase 5 inhibitors , CARNITINE
17 Terminated Effect of Sulodexide in Overt Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Sulodexide
18 Completed Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease;   Diabetes Type 2
Intervention: Drug: N-acetylcysteine
19 Completed Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Sevelamer Carbonate;   Drug: Calcium Carbonate
20 Recruiting Renal Denervation in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Persistent Proteinuria With Type II Diabetes
Interventions: Procedure: Percutaneous renal denervation and TMNS;   Drug: Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years